Tag: Cancer immunotherapy

Study authors disclose funding and industry roles with Theriva Biologics

September 30, 2026

Study authors disclose funding and industry roles with Theriva Biologics

Teclistamab Shows Higher Complete Response Rates in High-Risk Smoldering Multiple Myeloma

September 13, 2026

Teclistamab Shows Higher Complete Response Rates in High-Risk Smoldering Multiple Myeloma

How ROS and MEK Inhibition Prevent T Cell Exhaustion in Cancer Therapy

September 3, 2026

How ROS and MEK Inhibition Prevent T Cell Exhaustion in Cancer Therapy

Scientists Discover Hidden Switch That Helps Cancer Cells Evade Immune System

August 14, 2026

Scientists Discover Hidden Switch That Helps Cancer Cells Evade Immune System

Web Analytics